Antidepressants During Pregnancy: Stay on Them or Stop?
In December, two new studies on taking antidepressant drugs during pregnancy drew a lot of attention. The larger study, of nearly 850,000 births in Finland, found more short-term complications in newborns whose mothers used commonly prescribed antidepressants while pregnant. But the study also found benefits: lower risks of premature births and cesarean sections in women who took these drugs compared to women with untreated psychiatric disorders. Dr. Bryan King, program director of Seattle Children's Autism Center and a professor of psychiatry and behavioral sciences at the University of Washington, wrote an accompanying journal editorial about the study. He also was interviewed in a Seattle Children's blog to put the findings into perspective for parents.
About Seattle Children’s
Seattle Children’s mission is to provide hope, care and cures to help every child live the healthiest and most fulfilling life possible. Together, Seattle Children’s Hospital, Research Institute and Foundation deliver superior patient care, identify new discoveries and treatments through pediatric research, and raise funds to create better futures for patients.
Ranked as one of the top five children’s hospitals in the country by U.S. News & World Report, Seattle Children’s serves as the pediatric and adolescent academic medical center for Washington, Alaska, Montana and Idaho – the largest region of any children’s hospital in the country. As one of the nation's top five pediatric research centers, Seattle Children’s Research Institute is internationally recognized for its work in neurosciences, immunology, cancer, infectious disease, injury prevention and much more. Seattle Children’s Hospital and Research Foundation works with the Seattle Children’s Hospital Guild Association, the largest all-volunteer fundraising network for any hospital in the country, to gather community support and raise funds for uncompensated care and research.
For more information, visit seattlechildrens.org or follow us on Twitter, Facebook, Instagram or on our On the Pulse blog.